| Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance World Health Organization World Health Organization, 2023 | 1331* | 2023 |
| A systematic review and critical assessment of incentive strategies for discovery and development of novel antibiotics MJ Renwick, DM Brogan, E Mossialos The Journal of antibiotics 69 (2), 73-88, 2016 | 232 | 2016 |
| Incentivising innovation in antibiotic drug discovery and development: progress, challenges and next steps VL Simpkin, MJ Renwick, R Kelly, E Mossialos The Journal of antibiotics 70 (12), 1087-1096, 2017 | 230 | 2017 |
| Crowdfunding our health: economic risks and benefits MJ Renwick, E Mossialos Social Science & Medicine 191, 48-56, 2017 | 134 | 2017 |
| Targeting innovation in antibiotic drug discovery and development: The need for a One Health–One Europe–One World Framework MJ Renwick, V Simpkin, E Mossialos, World Health Organization World Health Organization. Regional Office for Europe, 2016 | 80 | 2016 |
| Postmarket policy considerations for biosimilar oncology drugs MJ Renwick, K Smolina, EJ Gladstone, D Weymann, SG Morgan The Lancet Oncology 17 (1), e31-e38, 2016 | 73 | 2016 |
| What are the economic barriers of antibiotic R&D and how can we overcome them? M Renwick, E Mossialos Expert opinion on drug discovery 13 (10), 889-892, 2018 | 71 | 2018 |
| Cost-effectiveness of cancer drugs: Comparative analysis of the United States and England A Cherla, M Renwick, A Jha, E Mossialos EClinicalMedicine 29, 2020 | 30 | 2020 |
| Structural equation model for estimating risk factors in type 2 diabetes mellitus in a Middle Eastern setting: evidence from the STEPS Qatar A Roman-Urrestarazu, FMH Ali, H Reka, MJ Renwick, GD Roman, ... BMJ Open Diabetes Research and Care 4 (1), e000231, 2016 | 22 | 2016 |
| International and European initiatives targeting innovation in antibiotic drug discovery and development MJ Renwick, V Simpkin, E Mossialos, E Mossialos, LSE Director The need of a one health-one Europe-one world framework. Den Haag, 1-93, 2016 | 13 | 2016 |
| Challenges to tackling antimicrobial resistance: economic and policy responses J North Cambridge University Press, 2020 | 12 | 2020 |
| Mathematical modelling of respiratory syncytial virus (RSV) in low-and middle-income countries: A systematic review A Mezei, J Cohen, MJ Renwick, J Atwell, A Portnoy Epidemics 35, 100444, 2021 | 10 | 2021 |
| Fostering clinical development and commercialisation of novel antibiotics M Renwick, E Mossialos Eurohealth 26 (1), 8-11, 2020 | 3 | 2020 |
| Cost‐Effectiveness of Cardiovascular, Obesity, and Diabetes Mellitus Drugs: Comparative Analysis of the United States and England A Cherla, M Renwick, G Stefanini, DR Holmes Jr, E Mossialos Journal of the American Heart Association 9 (21), e018281, 2020 | 1 | 2020 |
| Fostering R&D of novel antibiotics and other technologies to prevent and treat infection M Renwick, E Mossialos European Journal of Public Health 30 (Supplement_5), ckaa165. 1203, 2020 | 1 | 2020 |
| 25. I. Skills building seminar: Utilizing document review and content analysis for monitoring public health initiatives E Mossialos, M Renwick, E Mossialos European Journal of Public Health 30, 5, 2020 | | 2020 |
